COVID Intel - by William Makis (McGill Medicine)

COVID Intel - by William Makis (McGill Medicine)

IVERMECTIN and MEBENDAZOLE Testimonial - 34 year old Arizona woman with Stage 3 Breast Cancer has 80% tumor shrinkage of primary and 100% resolution of axillary nodes after 3.5 months!

William Makis's avatar
William Makis
Jun 18, 2025
∙ Paid
Ivermectin's Days in Court | MedPage Today

Keep reading with a 7-day free trial

Subscribe to COVID Intel - by William Makis (McGill Medicine) to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 William Makis
Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture